Federal contract award

75F40122F19022

RECORDS INFORMATION MANAGEMENT IDIQ

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541990 — All Other Professional, Scientific, and Technical Services
PSCR499 — Other Professional Services
Parent award / vehicle75F40120D00022
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$23.8M
Current contract value$23.8M
Potential contract value / ceiling$31.1M
Start dateJun 6, 2022
Current end dateMay 31, 2025
Potential end dateAug 26, 2025
Latest award activityJul 26, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 26, 2026P00007$-432.3KTHE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FUNDS AND CLOSEOUT THE CONTRACT.
Sep 2, 2025P00006$1.0MREVISED ALLOCATION OF PROGRAM MANAGER COSTS
Sep 17, 2024P00005$921.2KREVISED ALLOCATION OF PROGRAM MANAGER COSTS
Apr 24, 2024P00004$7.5MDOCUMENT ROOM OPERATIONS DOCUMENT ROOM (RIM)
Jun 20, 2023P00003$7.5MTHE PURPOSE OF THIS MODIFICATION IS TO ADD FULL FUNDING FOR OPTION YEAR 1 IN THE AMOUNT OF $7,485,458.00. THE PERIOD OF PERFORMANCE IS JUNE 1, 2023, TO MAY 31, 2024. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED.
May 30, 2023P00002$0THE PURPOSE OF THIS MODIFICATION IS TO: A) EXERCISE OPTION YEAR 1 - FROM: JUNE 1, 2023, TO MAY 31, 2024 B) CHANGE THE CONTRACTING OFFICER (CO). THE NEW CO FOR THIS ACTION IS IAN WEISS (IAN.WEISS@FDA.HHS.GOV). HE WILL BE THE ADMINISTERING CO FOR
Apr 18, 2023P00001$61.0KRECORDS INFORMATION MANAGEMENT IDIQ
Jun 6, 20220$7.2MRECORDS INFORMATION MANAGEMENT IDIQ

Research next steps

  1. Verify whether remaining options may extend performance beyond the current end date.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.